Skip to contentMCBRINN SYLVIA — BioAtla, Inc. insider: 13 transactions · InsiderLensMCBRINN SYLVIA
- EVP,Branded Pharmaceuticals at ANDRX CORP /DE/ · on record since Mar 31, 2004
- Director at BioAtla, Inc. · on record since Jun 17, 2021
Insider trading activity of MCBRINN SYLVIA
- Transactions on record
- 13
- since Jun 17, 2022
- Open-market buys
- 7
- $97.1K
- Open-market sells
- 0
- Companies traded
- 1
- last filing Jun 18, 2025
Figures computed from official regulatory filings — methodology.
Companies where MCBRINN SYLVIA has traded
Track record of MCBRINN SYLVIA
Statistical track record
Free- Open-market buys
- 7
- Last buy
- Dec 26, 2023
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of MCBRINN SYLVIA
Co-insiders of MCBRINN SYLVIA
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
Cormorant Private Healthcare Fund II, LPBioAtla, Inc.
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jun 18, 2025 | Award | 23,500 | 0.00 USD | $0 | SEC |
| Jun 14, 2024 | Award | 16,500 | 0.00 USD | $0 | SEC |
| Jan 19, 2024 | Buy | 4,000 | 2.35 USD | $9.4K | SEC |
| Dec 26, 2023 | Buy | 4,000 | 2.33 USD | $9.3K | SEC |
| Sep 13, 2023 | Buy | 2,000 | 2.54 USD | $5.1K | SEC |
| Jun 15, 2023 | AwardD | 50,000 | 0.00 USD | $0 | SEC |
| Dec 19, 2022 | Buy | 3,700 | 8.33 USD | $30.8K | SEC |
| Nov 23, 2022 | Buy | 2,000 | 8.27 USD | $16.5K | SEC |
| Sep 15, 2022 | Buy | 2,000 | 8.85 USD | $17.7K | SEC |
| Sep 15, 2022 | Buy | 1,000 | 8.20 USD | $8.2K | SEC |
| Jun 17, 2022 | AwardD | 20,000 | 0.00 USD | $0 | SEC |
| Jun 17, 2022 | AwardD | 5,695 | 0.00 USD | $0 | SEC |
| Jun 17, 2022 | AwardD | 18,920 | 0.00 USD | $0 | SEC |